Meeting Report
FDA and Its Role in Drug Development
Presented by Richard Pazdur, MD
From Oncology Center of Excellence, U.S. Food & Drug Administration, Silver Spring, Maryland
J Adv Pract Oncol 2021;12(3):293–295 |
https://doi.org/10.6004/jadpro.2021.12.3.15 |
© 2021 Harborside™
ABSTRACT
JADPRO Live 2020 was honored to have Dr. Richard Pazdur, the Director of the Oncology Center of Excellence at the FDA, discuss recent changes to oncology drug development and the approval process, the roles of the advanced practitioner in the execution of clinical trials, and changes that have taken place as a result of the COVID-19 pandemic.
For access to the full length article, please
sign in.
